| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 845 | 2021 |
| Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry L Izquierdo-Sanchez, A Lamarca, A La Casta, S Buettner, K Utpatel, ... Journal of hepatology 76 (5), 1109-1121, 2022 | 247 | 2022 |
| Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis and prognostication of cholangiocarcinoma A Lapitz, M Azkargorta, P Milkiewicz, P Olaizola, E Zhuravleva, ... Journal of hepatology, 2023 | 92 | 2023 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... Human molecular genetics 31 (23), 3945-3966, 2022 | 77 | 2022 |
| Patients with cholangiocarcinoma present specific RNA profiles in serum and urine extracellular vesicles mirroring the tumor expression: novel liquid biopsy biomarkers for … A Lapitz, A Arbelaiz, CJ O’Rourke, JL Lavin, A La Casta, C Ibarra, ... Cells 9 (3), 721, 2020 | 76 | 2020 |
| Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles I Martínez‐Arranz, C Bruzzone, M Noureddin, R Gil‐Redondo, I Mincholé, ... Hepatology 76 (4), 1121-1134, 2022 | 53 | 2022 |
| Genetics, pathobiology and therapeutic opportunities of polycystic liver disease P Olaizola, PM Rodrigues, FJ Caballero-Camino, L Izquierdo-Sanchez, ... Nature Reviews Gastroenterology & Hepatology, 1-20, 2022 | 29 | 2022 |
| Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: new therapeutic targets A Santos‐Laso, L Izquierdo‐Sanchez, PM Rodrigues, BQ Huang, ... Liver International 40 (7), 1670-1685, 2020 | 26 | 2020 |
| A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multi-organ activity and shows translational relevance to humans FJ Caballero-Camino, PM Rodrigues, F Wångsell, A Agirre-Lizaso, ... Hepatology, 10.1097, 0 | 25 | |
| High prevalence of insulin resistance in asymptomatic patients with acute intermittent porphyria and liver-targeted insulin as a novel therapeutic approach I Solares, L Izquierdo-Sánchez, M Morales-Conejo, D Jericó, ... Biomedicines 9 (3), 255, 2021 | 24 | 2021 |
| Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models PY Lee-Law, P Olaizola, FJ Caballero-Camino, L Izquierdo-Sanchez, ... Journal of hepatology 74 (2), 394-406, 2021 | 24 | 2021 |
| New advances in polycystic liver diseases A Santos-Laso, L Izquierdo-Sánchez, PY Lee-Law, MJ Perugorria, ... Seminars in Liver Disease 58 (01), 045-055, 2017 | 23 | 2017 |
| Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry LE Nooijen, JM Banales, MT De Boer, C Braconi, T Folseraas, A Forner, ... Cancers 14 (10), 2389, 2022 | 16 | 2022 |
| Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease AL Simão, CS Palma, L Izquierdo-Sanchez, A Putignano, ... JHEP Reports 5 (5), 100697, 2023 | 15 | 2023 |
| New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... medRxiv, 2021 | 14 | 2021 |
| Synthetic conjugates of ursodeoxycholic acid inhibit cystogenesis in experimental models of polycystic liver disease FJ Caballero‐Camino, I Rivilla, E Herraez, O Briz, A Santos‐Laso, ... Hepatology 73 (1), 186-203, 2021 | 10 | 2021 |
| Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease PY Lee‐Law, P Olaizola, FJ Caballero‐Camino, L Izquierdo‐Sanchez, ... UEG Journal 9 (7), 848-859, 2021 | 8 | 2021 |
| Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence LG Da Fonseca, PH Hashizume, IS de Oliveira, L Izquierdo-Sanchez, ... Cancers 14 (14), 3483, 2022 | 3 | 2022 |
| A look back at cholangiocarcinoma in Finland L Izquierdo‐Sanchez, JM Banales, PM Rodrigues United European Gastroenterology Journal 9 (10), 1103, 2021 | | 2021 |
| ZEB1 promotes cholangiocarcinoma progression through tumor dedifferentiation and paracrine signaling between tumor cells and cancer-associated fibroblasts J Vaquero, C Lobe, M Vallette, A Arbelaiz, C Coulouarn, ... Journal of Hepatology 73, S639, 2020 | | 2020 |
Luis Bujanda (ORCID 0000-0002-435...Catedrático de Medicina. Instituto Biodonostia. CIBERehd. UPV/EHUΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα osakidetza.eus